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Abstract
Background: Real-time three-dimensional transesophageal echocardiography (RT3D TEE) enables 
better visualization of the left atrial appendage (LAA) and may be superior to real-time two-dimensional 
transesophageal echocardiography (RT2D TEE) for LAA occlusion (LAAO). The aim of this study was 
to assess inter- and intra-observer variability of RT2D TEE and RT3D TEE measurements of LAA, 
and to assess the accordance of RT2D TEE and RT3D TEE with appropriate occluder selection.
Methods: Transesophageal echocardiography was performed in 40 patients during LAAO. RT2D 
TEE and RT3D TEE measurements of the ostium and landing zone were performed independently by 
two echocardiographers. The appropriate choice of occluder was confirmed with fluoroscopic criteria. 
After the procedures, RT2D TEE and RT3D TEE evaluation were repeated separately by the same 
echocardiographers. 
Results: The mean ostium diameters by RT2D TEE obtained by the two observers were 23.6 ± 4.2 vs. 
24.8 ± 5.2 (p = 0.04), and the mean landing zone diameters were 17.7 ± 4.4 vs. 19.4 ± 3.9 (p < 0.01). 
In the case of RT3D TEE, the ostium diameters were 29.6 ± 5.3 vs. 29.4 ± 6.4 (p = not significant 
[NS]) and the landing zone diameters were 21.4 ± 3.8 vs. 21.6 ± 3.9 (p = NS). Intra-observer differ-
ences were absent in the case of RT3D TEE. The comparison of RT2D TEE vs. RT3D TEE analyses 
performed by the same echocardiographer revealed significant differences in the ostium and landing 
zone measurements (both p < 0.01). Agreement between the suggested device size was better for RT3D 
TEE (weighted kappa was 0.62 vs. 0.28, respectively).
Conclusions: The results obtained with RT3D TEE showed significantly larger dimensions of the 
ostium and the landing zone. RT3D TEE showed lesser inter- and intra-observer variability and better 
agreement with the implanted device. (Cardiol J 2019; 26, 6: 687–695)
Key words: left atrial appendage occlusion, real-time two- and three-dimensional 
transesophageal echocardiography, Amplatzer Occluder
Introduction
Atrial fibrillation (AF) is the most common ar-
rhythmia worldwide and its prevalence is estimated 
to increase further because of population ageing [1]. 
The most dangerous complication of AF is ischemic 
cerebral stroke (ICS). Although oral anticoagulants 
(OAC) have proven to be effective in preventing 
ICS [2–4], its risk still remains high in AF patients 
[5]. In many patients, treatment with OAC may be 
contraindicated or risky because of conditions such 
as recurrent bleeding, low compliance, or drug 
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intolerance. Left atrial appendage (LAA) occlu-
sion (LAAO) may be considered as an alternative 
method for ICS prevention [6–8]. According to the 
guidelines of the European Society of Cardiology, 
LAAO may be considered in AF patients with high 
risk of ischemic stroke and contraindications for 
long-term oral anticoagulation [9].  
The technical and clinical success of LAAO 
depends on correct assessment of the ostium and 
the landing zone dimensions [10]. Selection of the 
optimal occluder size remains a challenge as each 
of the available imaging modalities have some 
limitations. The main methods of LAA imaging 
are: conventional cardiac angiography (CCA), 
transesophageal echocardiography (TEE), and 
cardiac computed tomography (CCT) angiography 
[11]. Recent data shows that CCT facilitates a more 
adequate occluder selection than real-time two-
dimensional transesophageal echocardiography 
(RT2D TEE), and reduces the risk of high-flow 
leaks and device malposition because of under 
sizing [12]. However, it is costly, requires injec-
tion of a contrast medium, and is not useful for 
guiding the procedure. Some analyses performed 
for aortic valve evaluation showed that real-time 
three-dimensional transesophageal echocardiog-
raphy (RT3D TEE) may provide more accurate 
assessment and its results are better correlated 
with CCT than RT2D TEE [13]. Till date no inter- 
or intra-observer studies comparing RT2D TEE 
and RT3D TEE in LAAO procedures have been 
conducted. 
Thus, the aim of this study was to compare 
RT2D TEE and RT3D TEE in LAAO performed by 
two independent echocardiographers to determine 
which method gives more reproducible results and 
facilitates the selection of the optimal occluder size.
Methods
Left atrial appendage occlusion was performed 
in 40 consecutive patients with both paroxysmal or 
persistent/permanent AF (mean age 70 ± 8 years; 
male 57%) of which 14 were in sinus rhythm during 
the procedure. In line with the current recommen-
dations, all patients had indications for ICS pre-
vention based on the CHA2DS2-VASc score (mean 
4.2 ± 1.5). Selection of patients was based on the 
EHRA/EAPCI expert consensus statement, which 
included: the presence of contraindications to OAC 
(e.g. thrombocytopenia, cancer), irreversibly high 
risk of bleeding according to the HAS-BLED score, 
and the presence of ICS despite OAC treatment 
[14]. The mean HAS-BLED score was 3.3 ± 0.9. 
Patients with a LAA thrombus, LAA dimension 
being too small or too large for LAAO, LAA depth 
< 10 mm, or an elongated shape of the ostium did 
not qualify for the procedure. Clinical characteristics 
of the study population are presented in Table 1.
LAAO procedure
The LAAO procedure was performed under 
general anesthesia. Access to the right atrium 
was obtained via the femoral vein. A transseptal 
puncture was performed to reach the left atrium. 
Heparin was subsequently administered to obtain 
activated clotting time above 250 s. After the in-
troduction of a pig-tail catheter to the LAA, CCA of 
the LAA was performed. The LAA was visualized 
from different views to find the largest diameter of 
the LAA neck. The procedures were guided by both 
fluoroscopy and transesophageal echocardiography.
Transesophageal echocardiography
Electrocardiographic (ECG) gated transeso-
phageal echocardiography was performed using 
Vivid E9 (6 VT-D probe; 5 MHz). On the day be-
fore LAAO, a pre-procedural TEE screening was 
performed to assess the LAA morphology, exclude 
an LAA thrombus, and verify the compatibility of 
the LAA neck dimension with the occluder size. 
The ostium, neck, and body of the LAA were 
visualized in different views. In case of RT2D TEE 
images, views obtained at ~45°, 90°, and 135° were 
analyzed. The left circumflex artery was visualized 
in each case as a reference point for detection of 
the landing zone. Three measurements were ob-
tained: dimension of the ostium (the line between 
the left lateral ridge and the ridge separating the 
LAA from the mitral valve), dimension of the land-
ing zone (starting approximately 10 mm from the 
left lateral ridge inside the LAA to a point located 
approximately 5 mm below the circumflex artery), 
and the depth of the LAA neck (an orthogonal line 
from the middle of the orifice into the back wall of 
the LAA). 
Table 1. Group characteristics.
Age [years] 70 ± 8 
Male [n] 57% [23]
HAS-BLED score 3.3 ± 0.9
CHA2DS2-VASc score 4.2 ± 1.5
Hypertension [n] 82% [33]
Diabetes [n] 37% [37]
Coronary heart disease [n] 75% [30]
Paroxysmal atrial fibrillation [n] 47% [19]
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RT3D TEE zoom images were obtained from one 
ECG cycle. Gain was adjusted to eliminate artefacts but 
not to allow for drop-out effect. The ostium and landing 
zone dimensions were measured in three perpendicu-
lar planes using the flexi-slice technique. The ostium 
level was measured between the pulmonary ridge 
and the tissue located between the mitral valve and 
circumflex artery. The landing zone level was assessed 
approximately 10 mm below the ostium. The largest 
diameter of LAA ostium was used as a reference for 
the selection of the occluder size (Fig. 1). 
All images were stored on a disk and after the 
procedure, two independent echocardiographers 
evaluated the RT2D TEE and RT3D TEE images 
for ostium and landing zone measurements. The 
dimensions of LAA ostium and landing zone were 
assessed twice by each echocardiographer on two dif-
ferent occasions to determine the method with more 
reproducible results. Based on the two results of LAA 
landing zone dimensions and the manufacturer siz-
ing chart, retrospectively the best occluder size was 
selected. The obtained results were then compared 
with the actual size of the implanted devices.
Occluder sizing
The Amplatzer Cardiac Plug or Amplatzer 
AMULET (St. Jude Medical, Minneapolis, MN, 
USA) were used for LAA closure. CCA was used as 
a referential method for occluder sizing under the 
condition that the difference with intraprocedural 
RT2D TEE or RT3D TEE measurement could not 
be more than 2 mm. If the difference was above 
2 mm then measurements were repeated. The size 
of the device was selected depending on the land-
ing zone dimension, according to the manufacturer 
sizing chart.
The post-procedural results were assessed 
with fluoroscopy and transesophageal echocardiog-
raphy. The criteria for optimal implantation were: 
separation between the device lobe and the disc, 
“tire-shaped” lobe, concave-shaped disc, axis of 
the device lobe parallel to the LAA neck axis, and 
> 2/3 of the lobe past the circumflex artery. 
Statistical analysis
The quantitative data was presented as mean 
± standard deviation (SD). Inter- and intra-observ-
er variability was analyzed with Student’s t-test for 
dependent samples. The Bland-Altman plot with 
multiple measurements per subject was used to 
assess whether RT2D TEE and RT3D TEE may 
be used interchangeably. The agreement  of RT2D 
TEE and RT3D TEE with the implanted device was 
calculated with weighted kappa statistics.
Figure 1. An example of flexi-slice real-time three-dimensional transesophageal echocardiography left atrial append-
age image analysis for the measurement of the landing zone dimension.
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Results
The mean ostium diameters by RT2D TEE 
measurements obtained by the two observers 
were 23.6 ± 4.2 vs. 24.8 ± 5.2 (p = 0.04), and the 
mean landing zone diameters were 17.7 ± 4.4 vs. 
19.4 ± 3.9 (p < 0.01). In the case of RT3D TEE, 
the mean ostium diameters were 29.6 ± 5.3 vs. 
29.4 ± 6.4 (p = not significant [NS]) and the landing 
zone diameters were 21.4 ± 3.8 vs. 21.6 ± 3.9 
(p = NS). Both the first and repeated measure-
ments of the LAA landing zone and ostium obtained 
with RT2D TEE were lower than those obtained 
with RT3D TEE (Fig. 2A, B). The differences were 
statistically significant.
Analysis of the RT2D TEE data obtained by the 
two echocardiographers showed significant differ-
ences, both with regard to the LAA ostium and the 
LAA landing zone assessment (both smaller when 
measured by echocardiographer A). Similar results 
Figure 2. Comparison of real-time two-dimensional transesophageal echocardiography (RT2D TEE) versus real-time 
three-dimensional transesophageal echocardiography (RT3D TEE) results of left atrial appendage (LAA) ostium and 
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were found in repeated analysis of RT2D TEE im-
ages. No such differences were seen in the RT3D 
TEE measurements. The inter-observer variability 
for RT2D TEE and RT3D TEE data is presented in 
Table 2 (primary analysis and reanalysis). 
The Bland-Altman plot with multiple meas-
urements per subject including repeated meas-
urements of the landing zone performed by both 
echocardiographers showed that the arithmetic 
mean difference between RT2D TEE and RT3D 
TEE dimension was 2.6 mm, and the lower and 
upper limits of difference were –10.2 mm and 
5.0 mm, respectively (Fig. 3). Such differences 
may have an effect on the selection of occluders.
Intra-observer variability was performed for 
both echocardiographers. The analysis of ostium 
and landing zone measurements obtained with 
RT2D TEE differed significantly for both echo-
Table 2. Inter-observer variability for RT2D TEE and RT3D TEE.
Diameter Echocardiographer A Echocardiographer B P 
Primary analysis
Ostium (RT2D TEE) [mm] 24.8 ± 5.2 23.6 ± 4.2 0.04
Landing zone (RT2D TEE) [mm] 19.4 ± 3.9 17.7 ± 4.4 < 0.01
Ostium (RT3D TEE) [mm] 29.4 ± 6.4 29.6 ± 5.3 NS
Landing zone (RT3D TEE) [mm] 21.6 ± 3.9 21.4 ± 3.8 NS
Repeated analysis
Ostium (RT2D TEE) [mm] 22.8 ± 4.2 24.3 ± 4.3 < 0.01
Landing zone (RT2D TEE) [mm] 18,1 ± 3.7 19.2 ± 3.6 < 0.01
Ostium (RT3D TEE) [mm] 28.6 ± 5.2 29.3 ± 5.0 NS
Landing zone (RT3D TEE) [mm] 21.2 ± 3.7 20.7 ± 3.8 NS
RT2D TEE — real time two-dimensional transesophageal echocardiography; RT3D TEE — real time three-dimensional transesophageal  
echocardiography
Figure 3. Bland-Altman plot with multiple measurements per subject for landing zone assessed with real-time two-
-dimensional transesophageal echocardiography (RT2D TEE) and real-time three-dimensional transesophageal echo-
cardiography (RT3D TEE).
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cardiographers. No such differences were seen in 
RT3D TEE analysis (Table 3).
Based on the dimension of the landing zone 
obtained with RT2D TEE and the sizing charts 
provided by the manufacturer, the suggested device 
size was assigned for each subject. The same was 
performed for the data obtained with RT3D TEE. 
The inter-rater agreement (kappa) between the 
size of the implanted device and that selected with 
RT3D TEE was good (weighted kappa = 0.68), 
whereas that selected with RT2D TEE was only 
fair (weighted kappa = 0.28) (Table 4A, B). 
Discussion
Appropriate occluder sizing is crucial for the 
safety and efficacy of LAAO. A TEE follow-up of 
patients randomized for LAAO with the Watchman 
device in the PROTECT-AF study revealed that up to 
32% of implanted patients had at least some degree of 
peri-device flow at 1 month [15]. Although presence of 
peri-device leak was  not associated with an increased 
risk of thromboembolism in that study, leaks over 
5 mm in width indicate insufficient protection against 
ICS. Underestimation of the landing zone dimension 
increases the risk of peri-device leak and is a risk factor 
for early device embolization [16], whereas excessive 
oversizing may increase the risk of left LAA wall tear 
or compression of the adjacent structures.
Different imaging modalities, such as CCT, 
TEE, magnetic resonance imaging and fluoroscopy 
are used to determine LAA anatomy [17]. Although 
CCT and fluoroscopy have been shown to facilitate 
better assessment of LAA than TEE, the latter still 
remains the standard tool for guidance of LAAO 
procedures.  
Clemente et al. [12] performed a pre-operative 
evaluation of LAA with TEE, CCT, intracardiac 
echocardiography, and CCA in 66 consecutive pa-
Table 3. Summary of intra-observer variability assessment for echocardiographer A and B (p value for 
T-test for dependent samples).
P value
Echocardiographer A Echocardiographer B
RT2D TEE Ostium 0.03 < 0.01
RT3D TEE Ostium NS NS
RT2D TEE Landing zone 0.03 0.01
RT3D TEE Landing zone NS NS
RT2D TEE — real-time two-dimensional transesophageal echocardiography; RT3D TEE — real-time three-dimensional transesophageal echo-
cardiography; NS — not significant
tients who underwent LAAO with the Amplatzer 
Cardiac Plug [12]. LAA diameters measured with 
CCT correlated with the diameters obtained with 
CCA and intracardiac echocardiography, but were 
slightly larger. TEE had a lower correlation with 
other imaging methods and a tendency to underes-
timate the LAA diameter. The authors concluded 
that CCT reduced device malposition because of 
under sizing. Similar findings were also reported 
by Vaitkus et al. [18] who found that CCT enables 
better visualization of LAA geometry and appro-
priate occluder selection. However, comparison 
between CCT and TEE for LAA evaluation was 
based on 2D imaging modality. Moreover, Budge 
et al. [19] compared the results of RT2D TEE with 
those obtained with planar CCT, and 3D segmented 
computed tomography reconstructions. They con-
cluded that LAA orifice measurements were not in-
terchangeable using these imaging modalities. The 
mean LAA orifice diameter in segmented CCT was 
larger (28.5  ±  4.5 mm) than planar CCT and TEE 
(26.3  ±  4.1 mm and 26.1  ±  6.4 mm, respectively).
The feasibility and accuracy of RT3D TEE in 
LAA morphology assessment was performed by 
Shah et al. [20]. The feasibility of RT3D TEE for 
LAA geometry was studied in the first 37 patients, 
whereas RT2D TEE and RT3D TEE quantifica-
tion of the LAA were compared in the subsequent 
29 patients. In 8 patients the data also correlated with 
CCT results. The LAA orifice area on CCT corre-
lated well with RT3D TEE data (r = 0.98) but not 
with RT2D TEE data (r = 0.13). The Bland-Altman 
analysis demonstrated that, compared with RT3D 
TEE, RT2D TEE systematically underestimated 
the LAA orifice area.
Recently Yosefey et al. [21] showed that RT3D 
TEE (24.5 ± 4.7 mm) vs. CCT (24.6 ± 5, p = NS) 
was more accurate in measuring the maximal LAA 
diameter compared to RT2D TEE (23.5 ± 3.9 mm) 
www.cardiologyjournal.org 693
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Table 4A. Inter-rater agreement (kappa) for devices selected with real time two-dimensional 
transesophageal echocardiography (RT2D TEE) and the implanted devices. Weighted kappa 0.28.
Implanted  
device 
Device by RT2D TEE
16 18 20 22 24 25 26 28 30 31 34
16 0 0 0 0 0 0 0 0 0 0 0 0 (0.0%)
18 1 1 0 1 0 0 0 0 0 0 0 3 (7.5%)
20 0 0 1 0 0 1 0 0 0 0 0 2 (5.0%)
22 1 0 6 1 0 0 0 3 0 1 0 12 (30.0%)
24 0 1 0 0 0 1 0 2 0 0 0 4 (10.0%)
25 0 0 0 1 0 2 0 1 0 0 0 4 (10.0%)
26 0 0 0 1 0 1 0 2 0 1 0 5 (12.5%)
28 0 0 0 2 0 2 0 2 0 0 0 6 (15.0%)
30 0 0 0 0 0 0 0 0 0 1 0 1 (2.5%)
31 0 0 1 0 0 0 0 0 0 0 0 1 (2.5%)
























Table 4B. Inter-rater agreement (kappa) for devices selected with real time three-dimensional 
transesophageal echocardiography (RT3D TEE) and the implanted devices. Wighted kappa 0.62.
Implanted 
device 
Device by RT3D TEE
18 20 22 24 25 26 28 30 31 34
18 1 1 1 0 0 0 0 0 0 0 3 (7.5%)
20 0 1 1 0 0 0 0 0 0 0 2 (5.0%)
22 0 2 6 0 3 0 1 0 0 0 12 (30.0%)
24 0 0 0 3 0 0 0 1 0 0 4 (10.0%)
25 0 0 0 0 2 0 0 0 2 0 4 (10.0%)
26 0 0 0 0 1 2 2 0 0 0 5 (12.5%)
28 0 0 1 0 1 0 3 0 0 1 6 (15.0%)
30 0 0 0 0 0 0 1 0 0 0 1 (2.5%)
31 0 0 0 0 0 0 0 0 1 0 1 (2.5%)






















vs. CTA (p < 0.01). However, the measurements 
were performed for the orifice, not the landing 
zone, which is the reference for occluder sizing. 
Moreover Nucifora et al. [22] showed higher cor-
relation of CCT with RT3D TEE for assessment 
of the LAA orifice area compared to RT2D TEE 
(r = 0.92, 95% CI 0.85–0.95 and r = 0.72, 95% CI 
0.55–0.83, respectively).
In accordance with the cited literature, results 
of the present study confirmed that the diameter of 
LAA ostium and LAA landing zone are considerably 
larger when assessed with RT3D TEE as compared 
with RT2D TEE. However, previous studies lacked 
a comparison between the results obtained with 
CCT or RT3D TEE and the actual fit of occluders 
used for LAAO. Neither the comparison of images 
after implantation nor the frequency of peri-device 
leak was analyzed for RT3D TEE or CCT. Despite 
previous recommendations for the use of RT2D 
TEE in occluder selection for LAAO, according to 
available research, the presented analysis shows 
the superiority of  RT3D TEE over RT2D TEE for 
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the first time. Moreover, RT3D TEE enables better 
imaging of the structures surrounding the LAA, 
thus reducing the probability of malposition. Use 
of RT3D TEE instead of RT2D TEE also generates 
practical advantages, such as avoiding potential 
complications, reducing radiation exposure, and/or 
shortening procedural times [23]. A possible limi-
tation of RT3D TEE may be the lack of standards 
for obtaining RT3D TEE images. Nevertheless, it 
is becoming an elementary navigation method for 
percutaneous procedures e.g. percutaneous mitral 
valve repair [24].
Although the accuracy of LAA assessment 
is similar for both RT3D TEE and CCT, the first 
does not require contrast agents. It is especially 
important in patients with renal failure quali-
fied for LAAO. Other advantages include cost 
effectiveness, lack of radiation, and lesser time 
consumption.
Conclusions
There are significant differences between 
RT2D TEE and RT3D TEE in the assessment of 
the LAA ostium and landing zone diameters. The 
results showed significantly larger dimensions 
of both the ostium and the landing zone obtained 
with RT3D TEE. RT2D TEE measurement of the 
ostium and landing zone dimensions were associ-
ated with significant inter- and intra-observer vari-
ability; no such differences were found for RT3D 
TEE results. RT3D TEE has a better agreement 
with the implanted occluders than RT2D TEE.
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